A children’s cancer charity has thanked its patron Alan Carr after he handed it £87,500 won through claiming victory on BBC show Celebrity Traitors on Thursday night.
The celebrity version of the show, in which ‘faithful’ contestants seek to unmask ‘traitors’, sees those taking part compete to raise money for their chosen charity.
After winning the comedian revealed he was handing the money to Neuroblastoma UK.
Carr has been involved with the charity for almost a decade, becoming a patron in 2016 after meeting parents who had lost children to the disease.
During the show 'traitor’ Carr managed to outsmart remaining faithfuls, actor Nick Mohammed and historian David Olusoga, in a tense finale, which is set to be the BBC’s most watched show this year.
“We can’t tell you how grateful we are,” said the charity in an open message to the comedian.
“We’ve adored watching you over the last three weeks; all the more so with that glimmer of hope that if you did well, it might just mean something big for our small charity. And you did it.
“As our faithful Patron for nine years, your commitment, compassion, and drive to bring hope to children and families facing this aggressive cancer have been nothing short of transformational. As a small charity with a big mission, you know how much this means to us.
“For many years, we’ve known you to be generous, warm, empathetic, and unfalteringly kind, and we’re so pleased the nation agrees with us on that.
"Now, we promise to do you proud. Our commitment to you is that through research, we will find better treatments and ultimately a cure for every child facing Neuroblastoma.”
Families and the charity’s supporters have also begun thanking Carr for his fundraising through the show.
“Congratulations Alan. This totally made my day. I lost my first child to this dreadful illness. Thank you for your good work,” said one.
Another added: “Well done to Alan Carr! And what a great way to raise awareness .”
Neuroblastoma UK head of fundraising and communications Emily Hood added: "The £87,500 contribution is extraordinary, and the surge in public support that’s followed is deeply encouraging for the future of childhood cancer research.
"It's been especially heartwarming to hear from parents who are currently going through the neuroblastoma journey with their child, who feel a renewed sense of hope with neuroblastoma being talked about on this national scale."








Recent Stories